Traws Pharma, Inc.TRAWNASDAQ
Loading
| Metric | Q2 2023 | Q4 2023 | Q2 2024 | Q4 2024 | Q2 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | -50.44% | -49.56% | +2318.58% |
| Gross Profit Growth | +0.00% | +0.00% | -50.44% | -49.54% | +2318.58% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +32.94% | +0.52% | +0.67% | +14.87% | +593.63% |
| Weighted Average Shares Diluted Growth | +32.94% | +0.52% | +0.67% | +14.87% | +593.63% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -37.04% | -35.71% | -35.71% | +5986.21% | +7682.35% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | -100.00% |
| Asset Growth | -31.34% | -59.11% | -61.13% | -36.60% | -48.73% |
| Book Value per Share Growth | -56.92% | -76.98% | +0.00% | +0.00% | -93.70% |
| Debt Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| R&D Expense Growth | +72.50% | +39.67% | -52.67% | -30.58% | -29.90% |
| SG&A Expenses Growth | -14.66% | +9.36% | -22.40% | -15.57% | -21.79% |